Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.
Cueva JF, Palacio I, Churruca C, Herrero A, Pardo B, Constenla M, Santaballa A, Manso L, Estévez P, Maximiano C, Legerén M, Marquina G, de Juan A, Quindós M, Sánchez L, Barquin A, Fernández I, Martín C, Juárez A, Martín T, García Y, Yubero A, Gallego A, Martínez Bueno A, Guerra E, González-Martín A. Cueva JF, et al. Eur J Cancer. 2023 Mar;182:3-14. doi: 10.1016/j.ejca.2022.12.023. Epub 2022 Dec 29. Eur J Cancer. 2023. PMID: 36706655
SEOM clinical guidelines for cervical cancer (2019).
de Juan A, Redondo A, Rubio MJ, García Y, Cueva J, Gaba L, Yubero A, Alarcón J, Maximiano C, Oaknin A. de Juan A, et al. Clin Transl Oncol. 2020 Feb;22(2):270-278. doi: 10.1007/s12094-019-02271-z. Epub 2020 Jan 24. Clin Transl Oncol. 2020. PMID: 31981078 Free article.
Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas J, Hurtado A, Garrigos L, Santaballa A, Redondo A, Vidal L, Lainez N, Guerra E, Rodriguez V, Cueva J, Bover I, Palacio I, Rubio MJ, Prieto M, Lopez-Guerrero JA, Rodriguez-Moreno JF, Garcia-Casado Z, Garcia-Martinez E, Taus A, de Castro IP, Navarro P, Grande E; Spanish Group for Research in Orphan, Infrequent Tumors (GETHI). Garcia-Donas J, et al. Among authors: cueva j. Clin Transl Oncol. 2023 Jul;25(7):2090-2098. doi: 10.1007/s12094-023-03085-w. Epub 2023 Jan 28. Clin Transl Oncol. 2023. PMID: 36708371 Clinical Trial.
Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study.
Garcia-Casado Z, Oaknin A, Mendiola M, Alkorta-Aranburu G, Antunez-Lopez JR, Moreno-Bueno G, Palacios J, Yubero A, Marquez R, Gallego A, Sanchez-Heras AB, Lopez-Guerrero JA, Perez-Segura C, Barretina-Ginesta P, Alarcon J, Gaba L, Marquez A, Matito J, Cueva J, Palacio I, Iglesias M, Arcusa A, Sanchez-Lorenzo L, Guerra-Alia E, Romero I, Vivancos A. Garcia-Casado Z, et al. J Pers Med. 2022 Nov 4;12(11):1842. doi: 10.3390/jpm12111842. J Pers Med. 2022. PMID: 36579549 Free PMC article.
Novel therapeutic approaches to the treatment of metastatic breast cancer.
Fernández Y, Cueva J, Palomo AG, Ramos M, de Juan A, Calvo L, García-Mata J, García-Teijido P, Peláez I, García-Estévez L. Fernández Y, et al. Cancer Treat Rev. 2010 Feb;36(1):33-42. doi: 10.1016/j.ctrv.2009.10.001. Epub 2009 Nov 1. Cancer Treat Rev. 2010. PMID: 19883980 Review.
Phase II trial of epirubicin at standard dose in relapsed ovarian cancer.
Peláez I, Lacave AJ, Palacio I, Alvarez E, Cueva JF, Muñiz I, Arranz F, Fra J. Peláez I, et al. Among authors: cueva jf. Eur J Cancer. 1996 May;32A(5):899-900. doi: 10.1016/0959-8049(96)00003-2. Eur J Cancer. 1996. PMID: 9081375 Clinical Trial. No abstract available.
34 results